- Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccineF Marc LaForce
Program for Appropriate Technology in Health, in Washington, DC, USA
Health Aff (Millwood) 30:1049-57. 2011..The vaccine's low cost--less than fifty cents per dose--makes it possible for the affected countries themselves to purchase vaccines for future birth cohorts...
- The Meningitis Vaccine ProjectF Marc LaForce
The Meningitis Vaccine Project, PATH, 13 Chemin du Levant, 01210 Ferney Voltaire, France
Vaccine 25:A97-100. 2007..The MVP model is a clear example of the usefulness of a "push mechanism" to finance the development of a needed vaccine for the developing world...